These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 16158953)
1. Sabarubicin- (MEN 10755) and paclitaxel show different kinetics in nuclear factor-kappaB (NF-kB) activation: effect of parthenolide on their cytotoxicity. Bellarosa D; Binaschi M; Maggi CA; Goso C Anticancer Res; 2005; 25(3B):2119-28. PubMed ID: 16158953 [TBL] [Abstract][Full Text] [Related]
2. Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo. Zhang D; Qiu L; Jin X; Guo Z; Guo C Mol Cancer Res; 2009 Jul; 7(7):1139-49. PubMed ID: 19584264 [TBL] [Abstract][Full Text] [Related]
4. Identification of the genes involved in enhanced fenretinide-induced apoptosis by parthenolide in human hepatoma cells. Park JH; Liu L; Kim IH; Kim JH; You KR; Kim DG Cancer Res; 2005 Apr; 65(7):2804-14. PubMed ID: 15805281 [TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest. Dziadyk JM; Sui M; Zhu X; Fan W Anticancer Res; 2004; 24(1):27-36. PubMed ID: 15015572 [TBL] [Abstract][Full Text] [Related]
6. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823 [TBL] [Abstract][Full Text] [Related]
7. Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells. Riganti C; Doublier S; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A Mol Pharmacol; 2008 Aug; 74(2):476-84. PubMed ID: 18463201 [TBL] [Abstract][Full Text] [Related]
8. Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest. Ralstin MC; Gage EA; Yip-Schneider MT; Klein PJ; Wiebke EA; Schmidt CM Mol Cancer Res; 2006 Jun; 4(6):387-99. PubMed ID: 16778086 [TBL] [Abstract][Full Text] [Related]
9. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model. Kang HJ; Lee SH; Price JE; Kim LS Breast J; 2009; 15(3):223-9. PubMed ID: 19645775 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis. Chovolou Y; Wätjen W; Kampkötter A; Kahl R Toxicology; 2007 Mar; 232(1-2):89-98. PubMed ID: 17223244 [TBL] [Abstract][Full Text] [Related]
11. 1'S-1'-acetoxyeugenol acetate: a novel phenylpropanoid from Alpinia conchigera enhances the apoptotic effects of paclitaxel in MCF-7 cells through NF-κB inactivation. In LL; Azmi MN; Ibrahim H; Awang K; Nagoor NH Anticancer Drugs; 2011 Jun; 22(5):424-34. PubMed ID: 21346553 [TBL] [Abstract][Full Text] [Related]
13. [Apoptotic effect of the combined treatment of engineered antibody with paclitaxel on BT474 cells]. Yin HJ; Cheng LS; Duan JL Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Mar; 23(3):260-3. PubMed ID: 17343796 [TBL] [Abstract][Full Text] [Related]
14. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells. Vadgama JV; Wu Y; Shen D; Hsia S; Block J Anticancer Res; 2000; 20(3A):1391-414. PubMed ID: 10928049 [TBL] [Abstract][Full Text] [Related]
15. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Tse AK; Wan CK; Shen XL; Yang M; Fong WF Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613 [TBL] [Abstract][Full Text] [Related]
16. Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells. Giri B; Gomes A; Sengupta R; Banerjee S; Nautiyal J; Sarkar FH; Majumdar AP Anticancer Res; 2009 Jan; 29(1):395-401. PubMed ID: 19331178 [TBL] [Abstract][Full Text] [Related]
17. Suppression of urokinase receptor expression by thalidomide is associated with inhibition of nuclear factor kappaB activation and subsequently suppressed ovarian cancer dissemination. Kobayashi H; Yagyu T; Kondo T; Kurita N; Inagaki K; Haruta S; Kawaguchi R; Kitanaka T; Sakamoto Y; Yamada Y; Kanayama N; Terao T Cancer Res; 2005 Nov; 65(22):10464-71. PubMed ID: 16288038 [TBL] [Abstract][Full Text] [Related]
18. Paclitaxel efficacy is increased by parthenolide via nuclear factor-kappaB pathways in in vitro and in vivo human non-small cell lung cancer models. Gao ZW; Zhang DL; Guo CB Curr Cancer Drug Targets; 2010 Nov; 10(7):705-15. PubMed ID: 20578985 [TBL] [Abstract][Full Text] [Related]
19. Parthenolide, an NF-κB inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer. Sohma I; Fujiwara Y; Sugita Y; Yoshioka A; Shirakawa M; Moon JH; Takiguchi S; Miyata H; Yamasaki M; Mori M; Doki Y Cancer Genomics Proteomics; 2011; 8(1):39-47. PubMed ID: 21289336 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Kim SM; Lee SY; Yuk DY; Moon DC; Choi SS; Kim Y; Han SB; Oh KW; Hong JT Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]